Small volume resuscitation with 7.5% hypertonic saline, hydroxyethyl starch 130/0.4 solution and hypertonic sodium chloride hydroxyethyl starch 40 injection reduced lung injury in endotoxin shock rats: Comparison with saline

Pulmonary Pharmacology and Therapeutics

Volumn 25, Issue 1, 2012, Pages 27-32

  Yu, Gaofeng ^a,b   Chi, Xinjin ^a   Hei, Ziqing ^a   Shen, Ning ^a   Chen, Jinghui ^a   Zhang, Wenhua ^a   Li, Shangrong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU WOMEN AND CHILDREN S MEDICAL CENTER   (China)

Author keywords

Endotoxin shock; Lung injury; Small volume resuscitation

Indexed keywords

HETASTARCH; HYDROGEN SULFIDE; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FLUID RESUSCITATION; LUNG INJURY; LUNG LAVAGE; LUNG PARENCHYMA; MALE; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SEPTIC SHOCK; SMALL VOLUME FLUID RESUSCITATION; TREATMENT OUTCOME;

ACUTE LUNG INJURY; ANIMALS; BLOOD PRESSURE; BRONCHOALVEOLAR LAVAGE FLUID; CAROTID ARTERIES; ENDOTOXINS; HEART RATE; HETASTARCH; HYDROGEN SULFIDE; L-LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDES; MALE; NITRIC OXIDE; ORGAN SIZE; OXYGEN CONSUMPTION; PLASMA SUBSTITUTES; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; SALINE SOLUTION, HYPERTONIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856805968     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2011.10.003     Document Type: Article

References (27)

1. Vladislara S., Katia B., Peter R., Eberhard B., Enrico C. Year in review 2006: critical care -multiple organ failure, sepsis, and shock. Crit Care 2007, 11:221-227.
2. Rivers E.P., McIntyre L., Morro D.C., Rivers K.K. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ 2005, 173:1054-1065.
3. Tumurkhuu G., Koide N., Dagvadorj J., Morikawa A., Hassan F., Islam S., et al. The mechanism of development of acute lung injury in lethal endotoxic shock using α-galactosylceramide sensitization. Clin Exp Immunol 2008, 152:182-191.
4. Berthiaume Y., Matthay M.A. Alveolar edema fluid clearance and acute lung injury. Respir Physiol Neurohiol 2007, 159:350-359.
5. Nascimento P., de Paiva Filho O., de Carvalho L.R., Braz J.R. Early hemodynamic and renal effects of hemorrhagic shock resuscitation with lactated Ringer's solution, hydroxyethyl starch, and hypertonic saline with or without 6% dextran-70. JSurg Res 2006, 136:98-105.
6. Somell A., Sollevi A., Suneson A., Riddez L., Hjelmqvist H. Beneficial effects of hypertonic saline/dextran on early survival in porcine endotoxin shock. Acta Anaesthesiol Scand 2005, 49:1124-1134.
7. Garrido Adel P., Cruz R.J., Poli de Figueiredo L.F., Rocha e Silva M. Small volume of hypertonic saline as the initial fluid replacement in experimental hypodynamic sepsis. Crit Care 2006, 10:R62.
8. Tokyay R., Zeigler S.T., Kramer G.C., Rogers C.S., Heggers J.P., Traber D.L., et al. Effects of hypertonic saline dextran resuscitation on oxygen consumption, and lipidperoxidation after burn injury. Trauma 1992, 32:704-712.
9. Hehlgans T., Pfeffer K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 2005, 115:1-20.
10. Collin M., Anuar F.B., Murch O., Bhatia M., Moore P.K., Thiemermann C. Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia. Br J Pharmacol 2005, 146:498-505.
11. Dugo L., Marzocco S., Mazzon E., Di Paola R., Genovese T., Caputi A.P., et al. Effects of GW274150, a novel and selective inhibitor of iNOS activity, in acute lung inflammation. Br J Pharmacol 2004, 141:979-987.
12. Thompson R., Greaves I. Hypertonic saline-hydroxyethyl starch in trauma resuscitation. JR Army Crops 2006, 152:6-12.
13. Cabrales P., Tsa A.G., Intalieglietta M. Resuscitation from hemorrhagic shock with hydroxyethyl starch and coagulation changes. Shock 2007, 28:461-467.
14. Hacas T., Fries D., Holz C., Innerhofer P., Streif W., Klingler A., et al. Less impairment of hemostasis reduce blood loss in pigs after resuscitation from hemorrhagic shock using the small-volume concept with hypertonic saline hydroxyethyl Starch as compared to administration of 4% gelatin or 6% hydroxyethyl starch solution. Anesth Analg 2008, 106:1078-1086.
15. Tian J., Lin X., Zhou W., Xu J. Hydroxyethyl starch inhibits NF -κB activation and prevents the expression of inflammatory mediators in endotoxic rats. Ann Clin Lab Sci 2003, 33:451-458.
16. Vane J., Botting R. Inflammation and the mechanism of action of anti-inflammatory drugs. FASEB J 1987, 1:89-96.
17. Sakka S.G., Klein M., Reinhart K., Meier-Hellmann A. Prognostic value of extravascular lung water in critically ill patients. Chest 2002, 122:2080-2086.
18. Michard F. Beside assessment of extravascular lung water by dilution methods: temptations and pitfalls. Crit Care Med 2007, 35:1186-1192.
19. Wisselink W., Patetsios P., Panetta T.F., Ramirez J.A., Rodino W., Kirwin J.D., et al. Medium molecular weight pentastarch reduced reperfusion injury by decreasing capillary leak in an animal model of spinal cord ischemia. JVasc Surg 1998, 27:109-116.
20. Shields C.J., Winter D.C., Manning B.J., Wang J.H., Kirwan W.O., Redmond H.P. Hypertonic saline infusion for pulmonary injury due to ischemia-reperfusion. Arch Surg 2003, 138:9-14.
21. Hatanaka E., Shimomi F.M., Curi R., Campa A. Sodium chloride inhibits cytokine production by lipopolysaccharide-stimulated human neutrophils and mononuclear cells. Shock 2007, 27:32-35.
22. Kimura Y., Kimura H. Hydrogen sulfide protects neurons from oxidative stress. FASEB J 2004, 18:1165-1167.
23. Bian J.S., Yong Q.C., Pan T.T., Feng Z.N., Ali M.Y., Zhou S., et al. Role of hydrogen sulphide in the cardioprotection caused by ischemic preconditioning in the rat heart and cardiac myocytes. JPharmacol Exp Ther 2006, 316:670-678.
24. Li L., Bhatia M., Zhu Y.Z., Zhu Y.C., Ramnath R.D., Wang Z.J., et al. Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005, 19:1196-1198.
25. Chauhan S.D., Seggara G., Vo P.A., Macallister R.J., Hobbs A.J., Ahluwalia A. Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J 2003, 17:773-775.
26. Payabvash S., Ghahremani M.H., Goliaei A., Mandegary A., Shafaroodi H., Amanlou M., et al. Nitric oxide modulates glutathione synthesis during endotoxemia. Free Radic Biol Med 2006, 41:1817-1828.
27. Razavi H.M., Wang L., Weicker S., Quinlan G.J., Mumby S., McCormack D.G., et al. Pulmonary oxidant stress in murine sepsis is due to inflammatory cell nitric oxide. Crit Care Med 2005, 33:1333-1339.